Spire Wealth Management Boosts Stock Position in Axon Enterprise, Inc (NASDAQ:AXON)

Spire Wealth Management grew its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 5.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 8,958 shares of the biotechnology company's stock after acquiring an additional 485 shares during the quarter. Spire Wealth Management's holdings in Axon Enterprise were worth $4,712,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Kentucky Retirement Systems Insurance Trust Fund acquired a new position in Axon Enterprise during the 1st quarter worth approximately $1,110,000. CX Institutional bought a new stake in shares of Axon Enterprise during the first quarter worth $115,000. Xponance Inc. increased its holdings in shares of Axon Enterprise by 3.5% during the fourth quarter. Xponance Inc. now owns 16,469 shares of the biotechnology company's stock worth $9,788,000 after buying an additional 560 shares in the last quarter. Brighton Jones LLC acquired a new position in shares of Axon Enterprise during the fourth quarter worth $480,000. Finally, Blue Trust Inc. lifted its stake in shares of Axon Enterprise by 33.1% in the 1st quarter. Blue Trust Inc. now owns 169 shares of the biotechnology company's stock valued at $89,000 after acquiring an additional 42 shares during the last quarter. Institutional investors own 79.08% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. The Goldman Sachs Group increased their target price on Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. Bank of America lifted their target price on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a research report on Wednesday, June 4th. Craig Hallum cut shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. Barclays lifted their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. Finally, Needham & Company LLC boosted their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a research note on Thursday, May 8th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $699.55.

Axon Enterprise Stock Up 1.0%

NASDAQ:AXON traded up $8.26 on Friday, hitting $812.21. The stock had a trading volume of 109,501 shares, compared to its average volume of 705,383. The company has a quick ratio of 2.62, a current ratio of 2.83 and a debt-to-equity ratio of 0.68. Axon Enterprise, Inc has a 52 week low of $279.02 and a 52 week high of $813.63. The business's fifty day moving average is $709.79 and its 200 day moving average is $629.30. The company has a market cap of $63.23 billion, a PE ratio of 196.19, a P/E/G ratio of 90.37 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.07. The firm had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The business's revenue was up 31.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.15 earnings per share. On average, equities research analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Insider Transactions at Axon Enterprise

In related news, President Joshua Isner sold 905 shares of the firm's stock in a transaction dated Tuesday, June 17th. The shares were sold at an average price of $776.39, for a total transaction of $702,632.95. Following the completion of the sale, the president now owns 268,735 shares in the company, valued at approximately $208,643,166.65. This trade represents a 0.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Brittany Bagley sold 3,400 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $700.00, for a total transaction of $2,380,000.00. Following the sale, the chief financial officer now owns 131,833 shares of the company's stock, valued at approximately $92,283,100. The trade was a 2.51% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 44,642 shares of company stock worth $30,500,428 in the last quarter. 4.40% of the stock is currently owned by corporate insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.